North America Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Country and Growth Forecast, 2025 - 2032

The North America Computational Pathology Market is expected to witness market growth of 7.4% CAGR during the forecast period (2025-2032).

The US market dominated the North America Computational Pathology Market by country in 2024, and is expected to continue to be a dominant market till 2032; thereby, achieving a market value of $321.3 million by 2032. The Canada market is experiencing a CAGR of 9.6% during 2025-2032. Additionally, the Mexico market is expected to exhibit a CAGR of 8.6% during 2025-2032.



This market is rapidly emerging as a transformative force in the medical and healthcare sectors, potentially revolutionizing how pathologists diagnose diseases and provide patient care. It integrates advanced technologies such as Artificial Intelligence (AI), Machine Learning (ML), and data analytics with traditional pathology practices to analyze medical data more accurately, efficiently, and in a way that enhances diagnostic capabilities.

The market is growing rapidly, driven by an increasing demand for precise diagnostics, personalized medicine, and more efficient workflows in laboratories and hospitals. Computational pathology, which uses computational algorithms to analyze pathology data, has many applications in clinical diagnostics, research, and personalized medicine. One key application is the automated analysis of digital pathology slides.

Canada’s government has pledged $198.6 billion over ten years to strengthen healthcare services, including $46.2 billion in new funding for provinces and territories. This investment aims to modernize healthcare infrastructure, reduce diagnostic delays, and enhance access to advanced technologies. These pathology stands to benefit significantly from this push, particularly in cancer care, pathology labs, and Indigenous health initiatives. As Canada focuses on improving early diagnosis and equitable healthcare delivery, the demand for scalable, AI-enabled diagnostic solutions like computational pathology is expected to rise considerably. In Mexico, cancer has become the third leading cause of death, with more than 195,000 new cases reported in 2020 alone. Breast, prostate, thyroid, colon, and cervical cancers are among the most prevalent, creating an urgent need for accurate and timely diagnosis. Computational pathology, with its ability to provide high-resolution digital imaging and AI-assisted tissue analysis, offers a powerful solution to Mexico’s growing cancer burden. In summary, the increasing healthcare investments in Canada, the rising cancer burden in Mexico, and the high per capita U.S. spending collectively drive substantial growth in the market across North America.

List of Key Companies Profiled

• Koninklijke Philips N.V.
• F.Hoffmann-La Roche Ltd.
• PathAI, Inc.
• Hamamatsu Photonics K.K.
• Olympus Corporation
• Visiopharm A/S
• Mikroscan Technologies, Inc.
• MindPeak GmbH
• Indica Labs, LLC
• Nucleai, Inc. (Nucleai)

Market Report Segmentation

By Component

• Software
• Services

By Application

• Disease Diagnosis
• Drug Discovery & Development
• Academic Research

By End-use

• Hospitals and Diagnostic Labs
• Biotechnology & Pharmaceutical Companies
• Academic and Research Institutes
• Other End-use

By Technology

• Machine Learning (ML)
• Deep Learning
• Other Machine Learning (ML)
• Computer Vision
• Natural Language Processing (NLP) Models
• Other Technology

By Country

• US
• Canada
• Mexico
• Rest of North America